Basel, Switzerland – March 21, 2017 – THERACHON AG, a biotechnology company focused on rare genetic diseases, announced today it has appointed Dr. Maarten Kraan, Ph.D., M.D., to the role of…
Basel, Switzerland – February 15, 2017 – THERACHON AG, a biotechnology company focused on rare genetic diseases, announced today the strengthening of its Board of Directors and executive management team. Hans Schikan,…
Basel, Switzerland – Jan. 5, 2017 – Therachon AG, a biotechnology company focused on rare genetic diseases, today announced it has appointed Luca Santarelli, M.D., as Chief Executive Officer and Director,…
